Citigroup’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Citigroup's MRNA Position: Q3 2026 in Review
Citigroup increased its Moderna (MRNA) stake by 4.7% in Q3 2026, buying an estimated $10.9M and bringing the position to 2,266,479 shares worth $436M. The position accounts for 0.14% of the portfolio, ranked #134.
Citigroup first reported a position in MRNA in Q1 2019 and has held it in 31 quarters since. 1,028 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Citigroup held 2,266,479 shares of Moderna worth $436M as of Q3 2026.
- Citigroup bought 101,065 Moderna shares in Q3 2026, an estimated $10.9M.
- Moderna made up 0.14% of Citigroup's portfolio in Q3 2026, its #134 holding.
- Citigroup first reported a position in Moderna in Q1 2019 and has held it in 31 quarters since.
- 1,028 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.